Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Upstream binding protein 1 (UBP1) is a member of the TFCP2/Grainyhead family of transcription factors, also known as LBP-1a. UBP1 functions as a nuclear DNA-binding transcriptional activator or repressor depending on promoter context and regulates transcription of several genes, including CYP11A1 (involved in steroid biosynthesis) and the alpha-globin gene in erythroid cells. It plays roles in modulating cholesterol and steroid metabolism, regulating placental gene expression, and repressing HIV-1 transcription. Genetic studies associate the UBP1 locus with blood pressure regulation. UBP1 is implicated in cancer biology, but its precise mechanistic impact on oncogenesis is still emerging. It operates in a network with related transcription factors and may regulate gene expression through dimerization and interaction with other LBP proteins[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream binding protein 1 (UBP1).